A Multicenter, Open-Label, Flexible Dose Study to Assess the Long-Term Safety of Pharmaceutical Cannabidol Oral Solution as an Adjunctive Treatment for Pediatric and Adult Subjects with a Treatment-Resistant Seizure Disorder who Complete...